Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

Alembic's revenue from operations rose to Rs 1,692.74 crore in Q3FY25, a 3.8 per cent Y-o-Y increase from Rs 1,630.57 crore ...

Q3 2025 Earnings Call Transcript January 30, 2025 Takeshi Horikoshi: This is Horikoshi, the CFO. I will go through the ...

The company's revenue from operations increased 3 percent to Rs 11,550 crore as against Rs 11,233 crore in the corresponding ...

Tata Chemicals Ltd on Monday (February 3) reported a net loss of ₹21 crore for the third quarter against a net profit of ₹194 ...

Generic injectables maker Gland Pharma on February 3 reported a 7% rise in third-quarter profit, as lower expenses helped ...

For Nifty-50 index, 23,270 and 23,100 would act as key support zones, while the 50-day SMA, 23,810 and 23,900 could be the ...

Booz Allen Hamilton (BAH) reported Q3 EPS of $1.55, beating estimates of $1.51. Sales of $2.92B and backlog growth of 14.8% ...

While announcing its Q3 quarterly results, the PSU said its Board of Directors has declared an interim dividend for the ...

When compared on a sequential basis, Premier Energies reported a 12.2% growth in its topline, while its EBITDA grew by 35%.

India's Larsen & Toubro reported a third-quarter profit miss on Thursday, and said its quarterly order growth quickened ...